Harvard University Office of Technology Development Collaborative Research Opportunity Finder

1. James Rowlett, PhD

   Anxiety, addiction, cognition, and sleep: pharmacotherapy, GABA receptor

   Investigate the neuropharmacological basis of psychiatric disease and addiction, employing behavioral methodologies and translational approaches.  Primary areas of research include anxiety, ...

   

2. Roger Spealman, PhD

   CNS disorders: addiction; Parkinson’s disease

   Studies on the mechanisms and efficacy of psychoactive drugs  

   

Research Categories

Therapeutics

Sub-categories

1. Drug Development: Non-Biologic Therapeutics and Small Molecules

   1. Adamantane»
   2. Anti-bacterial therapy»
   3. Anti-convulsant therapy»
   4. Anti-viral therapeutics»
   5. Anticancer therapy»
   6. Anticoagulant»
   7. Anticonvulsant therapy»
   8. Antifungal»
   9. Antimicrobial»
   10. Antioxidant»
   11. Antiviral small molecules»
   12. Antizyme»
   13. Anxiolytic»
   14. Benzodiazepine»
   15. Biologically-active small molecule»
   16. Cancer targets»
   17. Combination therapy»
   18. D-amino acids»
   19. DNA damaging agents»
   20. Double mimetic»
   21. EdU»
   22. HAART»
   23. Iressa»
   24. Medicinal chemistry»
   25. Muscle relaxant»
   26. Natural product»
   27. Natural products»
   28. Opioid»
   29. Peptide mimetic»
   30. Pharmacological agents»
   31. Prodrug»
   32. Recombinant toxins»
   33. Resveratol»
   34. Sedative»
   35. Small molecule chemistry»
   36. Small molecule inhibitors»
   37. Small molecule screens»
   38. Small molecule therapy»
   39. Small molecules»
   40. Soil microbe»
   41. Tarceva»